1. Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer
   Christian Bailly, 2022, European Journal of Pharmacology CrossRef
2. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation
   Aqeel Imran et al, 2021, Bioorganic Chemistry CrossRef